As the nation continues to confront the coronavirus outbreak, Blue Cross and Blue Shield (BCBS) companies are supporting patients, health care partners and communities with more than $11 billion committed to the fight.
BCBS companies have enhanced access to coronavirus care by eliminating key costs and are ensuring that health care systems and physician practices have the financial and medical resources they need to treat patients now and after this pandemic.
Congress made $175 BILLION in relief funds available to the Department of Health and Human Services to send direct assistance to HOSPITALS and HEALTH CARE PRACTITIONERS.
Source: U.S. Department of Health and Human Services, "CARES Act Provider Relief Fund: General Information."
Older adults, people of color, individuals with an underlying medical condition or those who are immunocompromised may be at a HIGHER RISK OF SERIOUS ILLNESS due to COVID-19.
Source: Centers for Disease Control and Prevention
THREE VACCINES have been approved for emergency use in the U.S. and several others are in Phase 3 of clinical trials. Globally, researchers are currently testing 78 VACCINES with humans.
Source: New York Times, “Coronavirus Vaccine Tracker,” March 20, 2021.